Upgrade to SI Premium - Free Trial

Natera and TransCode team up on colorectal cancer MRD trial

October 13, 2026 7:30 AM
Natera, Inc. (Nasdaq: NTRA) and TransCode Therapeutics, Inc. (Nasdaq: RNAZ) have announced a collaboration to support patient enrollment in TransCode's ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

FDA